Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

113.03 -0.96 (-0.84%)
Streaming Delayed Price Updated: 11:43 AM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agilent Technologies

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
10 Biggest Price Target Changes For Wednesday
Telsey Advisory Group cut Ralph Lauren Corporation (NYSE: RL) price target from $160 to $140. Ralph Lauren shares fell 3% to $88.40 in pre-market trading. 
Via Benzinga
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Earnings Scheduled For May 24, 2022
Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is estimated to report quarterly earnings at $1.89 per share on revenue of $1.26 billion. 
Via Benzinga
Analyst Ratings for Agilent Technologies
Within the last quarter, Agilent Technologies (NYSE:A) has observed the following analyst ratings: 
Via Benzinga
$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much
Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.86% on an annualized basis producing an average annual return of 15.33%. Currently, Agilent Technologies has a... 
Via Benzinga
Agilent Technologies's Earnings: A Preview
Agilent Technologies (NYSE:A) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Agilent... 
Via Benzinga
Agilent Announces Cash Dividend of 21 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Peering Into Agilent Technologies's Recent Short Interest
Agilent Technologies's (NYSE:A) short percent of float has risen 30.22% since its last report. The company recently reported that it has 5.41 million shares sold short, which is 1... 
Via Benzinga
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
From Agilent Technologies Inc.
Via Business Wire
If You Invested $1000 In Agilent Technologies 15 Years Ago, Here's How Much You Would Have Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.03% on an annualized basis producing an average annual return of 8.21%. Currently, Agilent Technologies has a... 
Via Benzinga
Analyzing Agilent Technologies Inc's Short Interest
Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 6.71% since its last report. The company recently reported that it has 4.16 million shares sold short, which... 
Via Benzinga
Agilent to Announce Second-Quarter Fiscal Year 2022 Financial Results May 24
From Agilent Technologies Inc.
Via Business Wire
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was... 
Via Benzinga
Agilent Joins the National Institute for Innovation in Manufacturing to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
From Agilent Technologies Inc.
Via Business Wire
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Health remains a tricky investment area, but Evercore analysts say there are safe bets. 
Via Investor's Business Daily
Agilent Joins AMBIC to Advance Biomanufacturing
From Agilent Technologies Inc.
Via Business Wire
Analyzing Agilent Technologies Inc's Short Interest
Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 9.2% since its last report. The company recently reported that it has 4.42 million shares sold short, which... 
Via Benzinga
20 Dividend Contenders Collapsing As The Bear Growls
Dividend Contenders are mostly fast-growing dividend growth stocks that increase their dividends for 10 to 25 consecutive years. 
Via Talk Markets
Analyzing Agilent Technologies Inc's Short Interest
Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 6.86% since its last report. The company recently reported that it has 4.89 million shares sold short, which... 
Via Benzinga
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.57% on an annualized basis. Buying $1,000 In A: 10 years ago, an investor could have... 
Via Benzinga
Looking Into Agilent Technologies Inc's Recent Short Interest
Agilent Technologies Inc's (NYSE:A) short percent of float has risen 7.36% since its last report. The company recently reported that it has 5.24 million shares sold short, which... 
Via Benzinga
Agilent to Participate at Cowen and Barclays Health Care Conferences
From Agilent Technologies Inc.
Via Business Wire
Agilent and University of Vermont Announce the Agilent Laboratory for Chemical Analysis (ALCA)
From Agilent Technologies Inc.
Via Business Wire
Expert Ratings For Agilent Technologies
Over the past 3 months, 4 analysts have published their opinion on Agilent Technologies (NYSE:A) stock. These analysts are typically employed by large Wall Street banks and tasked... 
Via Benzinga
Agilent's Q1 FY22 Earnings Beat Expectations, FY22 Guidance Surpass Street Estimates
Agilent Technologies Inc (NYSE: A) reported Q1 FY22 revenues rose 8% Y/Y to $1.67 billion, beating analysts average estimate of $1.46 billion. The firm said core... 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.